title: Lack of effect of eicosapentaenoic acid in preventing cancer cachexia and inhibiting tumor growth.
abstract: It has been recently reported that a diet enriched in n-3 polyunsaturated fatty acids reduces the growth of different kinds of tumors as well as the host tissue hypercatabolic state frequently associated. The rat ascites hepatoma Yoshida AH-130 is a fast growing tumor that causes a rapid and progressive body weight loss in the host and tissue waste associated with a hypercatabolic condition. Plasma levels of classical hormones and humoral mediators (prostaglandin E2 and tumor necrosis factor-alpha) are early perturbed after tumor transplantation (Tessitore, L., Costelli, P. and Baccino, F.M. (1993) Humoral mediation for cachexia in tumour-bearing rats. Br. J. Cancer, 67, 16-23). Enhanced protein degradation rates and alteration of lipoprotein lipase activity mainly account for the wasting of protein and adipose mass, respectively. However, the daily intragastric administration of eicosapentaenoic acid (1.5 g/kg body wt) to AH-130 bearing rats was completely ineffective either in preventing tissue waste or in reducing tumor growth. The low degree of differentiation and the high growth rate of the AH0130 hepatoma probably account for this lack of effect.
authors.affiliation: Dipartimento di Medicina ed Oncologia Sperimentale, Universita di Torino, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Costelli
authors.forename: M
authors.initials: M
authors.lastname: Llovera
authors.forename: J
authors.initials: J
authors.lastname: López-Soriano
authors.forename: N
authors.initials: N
authors.lastname: Carbó
authors.forename: L
authors.initials: L
authors.lastname: Tessitore
authors.forename: F J
authors.initials: FJ
authors.lastname: López-Soriano
authors.forename: F M
authors.initials: FM
authors.lastname: Baccino
authors.forename: J M
authors.initials: JM
authors.lastname: Argilés
mesh_terms: D000818:Animals; D002100:Cachexia / Q000517:prevention & control*; D004032:Diet; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D004734:Energy Metabolism / Q000187:drug effects; D008071:Lipoprotein Lipase / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism*; D008297:Male; D009124:Muscle Proteins / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D014280:Triglycerides / Q000097:blood
chemical_list: D009124:Muscle Proteins; D014280:Triglycerides; D015118:Eicosapentaenoic Acid; D008071:Lipoprotein Lipase